Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Advances in Radiopharmaceutics (Volume II)"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 August 2023 | Viewed by 1913
Special Issue Editor
Interests: PET; SPECT; multimodality; imaging analysis; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
The development of radiopharmaceuticals is important for diagnosis and/or radionuclide therapy in nuclear medicine with positron emission tomography (PET) and single-photon emission computed tomography (SPECT). It also has translational potential from preclinical study to clinical in oncology, neurodegenerative diseases, cardiovascular diseases, etc., for personalized medicine. Integrative imaging and therapy, in combination with other modalities, such as magnetic resonance imaging, ultrasonography, near-infrared imaging, etc., may move personalized medicine further. In addition, advances in PET and SPECT scanners emphasize the usefulness of radiopharmaceuticals.
This Special Issue focuses on the synthesis and evaluation of new radiopharmaceuticals, other applications of radiopharmaceuticals for clinical use, and the combination of radionuclides with other modalities. Novel PET and SPECT machines are also a target. However, the areas of interest are not limited to these keywords.
Dr. Masato Kobayashi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- imaging scanner